Shopify Down Nearly 9%, on Pace for Largest Percent Decrease Since February 2023 — Data Talk
Shopify, Inc. Class A (SHOP) is currently at $81.25, down $7.87 or 8.83%
--Would be lowest close since Feb. 1, 2024, when it closed at $76.72
--On pace for largest percent decrease since Feb. 16, 2023, when it fell 15.88%
--Currently down two consecutive days; down 10.44% over this period
--Worst two day stretch since the two days ending Oct. 26, 2023, when it fell 10.81%
--Up 1.47% month-to-date
--Up 4.3% year-to-date
--Down 51.94% from its all-time closing high of $169.06 on Nov. 19, 2021
--Up 62.14% from 52 weeks ago (Feb. 14, 2023), when it closed at $50.11
--Down 10.44% from its 52-week closing high of $90.72 on Feb. 9, 2024
--Up 102.62% from its 52-week closing low of $40.10 on March 1, 2023
--Traded as low as $77.15; lowest intraday level since Feb. 1, 2024, when it hit $75.82
--Down 13.43% at today's intraday low; largest intraday percent decrease since Feb. 16, 2023, when it fell as much as 17.02%
All data as of 10:15:41 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 13, 2024 10:33 ET (15:33 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track